Bavarian Nordic

Bavarian Nordic, headquartered in Denmark and operating in Pharmaceutical Preparation Manufacturing, reported total emissions of approximately 54,365,000 kg CO2e in 2024. This includes Scope 1 emissions of approximately 4,111,000 kg CO2e, market-based Scope 2 emissions of approximately 5,222,000 kg CO2e, and Scope 3 emissions of approximately 45,032,000 kg CO2e. Key contributors to their Scope 3 emissions in 2024 were purchased goods and services (approximately 26,111,000 kg CO2e), capital goods (approximately 5,399,000 kg CO2e), and upstream transportation and distribution (approximately 4,503,000 kg CO2e).

In 2023, Bavarian Nordic's total emissions were approximately 97,706,000 kg CO2e, comprising Scope 1 emissions of approximately 4,364,000 kg CO2e, market-based Scope 2 emissions of approximately 6,318,000 kg CO2e, and Scope 3 emissions of approximately 87,024,000 kg CO2e.

Bavarian Nordic is committed to achieving Net Zero emissions by 2050, in line with the Paris Agreement on Climate Change. They plan to focus on defining their carbon footprint reduction pathway in 2024. The company has also committed to near-term targets with the Science Based Targets initiative (SBTi) as of October 2024.